PharmaSGP Holding SE Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
26.00
21.00
15.00
14.00
14.00
22.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-11.00
-5.00
1.00
-3.00
9.00
-3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
21.00
22.00
22.00
11.00
15.00
17.00
Cash Flow from Investing Activities
-1.00
0.00
0.00
-83.00
0.00
0.00
Cash Flow from Financing Activities
-33.00
-13.00
-10.00
84.00
-94.00
-5.00
Net Cash Inflow / Outflow
-14.00
8.00
11.00
12.00
-80.00
11.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of PharmaSGP Holding SE
Figures in Million
consolidated Cash Flow Results
Change(EUR)
Change(%)
Profit Before Tax
26.04
-129.079
155.00
120.17%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-11.135
-11.82
0.00
5.80%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
21.084
-22.958
43.00
191.84%
Cash Flow from Investing Activities
-1.472
-2.635
1.00
44.14%
Cash Flow from Financing Activities
-33.888
40.391
-73.00
-183.90%
Net Cash Inflow / Outflow
-14.276
14.798
-28.00
-196.47%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -6.91% vs -1.13% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
21.08
22.65
-6.91%






